AGP Executive Report
Last update: 11 hours agoPharma: A Dutch court has ordered Merck to stop selling injectable Keytruda in Switzerland and seven other European markets, finding that it infringed Halozyme’s drug-delivery patent. Merck disputes the ruling and is weighing its options. Rail Manufacturing: Stadler secured a CHF300 million contract to supply trains to Saudi Arabia. Logistics: A Swiss logistics giant is deepening its China push as AI investment and Chinese multinationals expand. Energy: Investment has been approved for two semi-reservoir hydropower projects, while Swiss parties have submitted a referendum to preserve the ban on new nuclear plants. Industry & Demand: Sika acquired polymeric sands maker Azpects Group; Swiss consumers are still spending despite rising prices.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.